Skip to content

Clinical trials

Phase 2 Carcinoma, Renal Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 2 Country / region: Germany Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20073
20084
20093
20101
20111
20122
20142
20151
20162
20173
20181
20191
20202
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated5
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Hoffmann-La Roche5
Novartis Pharmaceuticals5
AIO-Studien-gGmbH2
Pfizer2
AVEO Pharmaceuticals, Inc.1
Association of Urologic Oncology (AUO)1
Calithera Biosciences, Inc1
Central European Society for Anticancer Drug Research1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell31
Kidney Neoplasms5
Carcinoma3
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Adenocarcinoma2
Breast Neoplasms2
Colorectal Neoplasms2
Head and Neck Neoplasms2
Neoplasm Metastasis2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.